Abstract
Purpose
Patients undergoing in-vitro fertilization (IVF) with preimplantation genetic screening (PGS) are counseled about the limitations of this technique. As part of the consent process for PGS, physicians recommend diagnostic genetic testing performed in early pregnancy to definitively rule out chromosomal abnormalities. We have noted anecdotally, however, that few patients undergo the recommended diagnostic testing. In this study, we are examining if women who conceived using IVF-PGS did early pregnancy chromosomal testing, and if they did, what type of testing they had.
Methods
This study was performed from 2015 to 2017 in the Division of Reproductive Endocrinology and Infertility at Northwestern University. We included patients who became pregnant after IVF-PGS who were seen by the Division of Reproductive Genetics and non-PGS control group.
Results
Sixty-eight patients were included. A total of 50 patients (73.5%) opted for non-invasive prenatal screening; 5 (7.4%) had invasive testing (4 had chorionic villus sampling and 1 had amniocentesis). A total of 13 patients (19%) declined further genetic testing. When comparing demographic data, the mean age was significantly higher in the group of patients who pursued non-invasive testing than in the group who declined further testing (37.15 vs 34.05 years old, p < 0.05). Control group declined invasive diagnostic testing.
Conclusions
Most patients who conceive using IVF-PGS do not pursue diagnostic prenatal chromosomal testing. Future studies focusing on decision making in this patient group are warranted to further elucidate why a small percentage of patients opt for diagnostic testing, even when adequately counseled about the inherent limitations of PGS.
Similar content being viewed by others
References
Munné S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities **Presented at the 50th Annual Meeting of The American Fertility Society, San Antonio, Texas, November 4 to 9, 1994, where it was awarded the prize paper of the Society for Assisted Reproductive Technology. Fertil Steril. 1995;64(2):382–91. https://doi.org/10.1016/s0015-0282(16)57739-5.
Bielanska M, Tan SL, Ao A. Chromosomal mosaicism throughout human implantation development in vitro: incidence, type, and relevance to embryo outcome. Hum Reprod. 2002;17(2):413–9. https://doi.org/10.1093/humrep/17.2.413.
Munné S, Sandalinas M, Magli C, Gianaroli L, Cohen J, Warburton D. Increased rate of aneuploid embryos in young women with previous aneuploid conceptions. Prenat Diagn. 2004;24(8):638–43. https://doi.org/10.1002/pd.957.
Kuliev A, Cieslak J, Verlinsky Y. Frequency and distribution of chromosome abnormalities in human oocytes. Cytogenet Genome Res. 2005;111(3–4):193–8. https://doi.org/10.1159/000086889.
Magli MC, Gianaroli L, Ferraretti AP, Lappi M, Ruberti A, Farfalli V. Embryo morphology and development are dependent on the chromosomal complement. Fertil Steril. 2007;87(3):534–41. https://doi.org/10.1016/j.fertnstert.2006.07.1512.
Munné S, Chen S, Colls P, Garrisi J, Zheng X, Cekleniak N, et al. Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod BioMed Online. 2007;14(5):628–34. https://doi.org/10.1016/S1472-6483(10)61057-7.
Hassold T, Hunt P. Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew. Curr Opin Pediatr. 2009;21(6):703–8. https://doi.org/10.1097/MOP.0b013e328332c6ab.
Gleicher N, Vidali A, Braverman J, Kushnir VA, Barad DH, Hudson C, et al. Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos. Reprod Biol Endocrinol. 2016;14(1):54. https://doi.org/10.1186/s12958-016-0193-6.
Kokkali G, Traeger-Synodinos J, Vrettou C, Stavrou D, Jones GM, Cram DS, et al. Blastocyst biopsy versus cleavage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of beta-thalassaemia: a pilot study. Hum Reprod. 2007;22(5):1443–9. https://doi.org/10.1093/humrep/del506.
Vera-Rodriguez M, Rubio C. Assessing the true incidence of mosaicism in preimplantation embryos. Fertil Steril. 2017;107(5):1107–12. https://doi.org/10.1016/j.fertnstert.2017.03.019.
Paulson RJ. Preimplantation genetic screening: what is the clinical efficiency? Fertil Steril. 2017;108(2):228–30. https://doi.org/10.1016/j.fertnstert.2017.06.023.
Akolekar R, Beta J, Picciarelli G, Ogilvie C, D'Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45(1):16–26. https://doi.org/10.1002/uog.14636.
Devers PL, Cronister A, Ormond KE, Facio F, Brasington CK, Flodman P. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns. 2013;22(3):291–5. https://doi.org/10.1007/s10897-012-9564-0.
Brezina PR, Kutteh WH, Bailey AP, Ke RW. Preimplantation genetic screening (PGS) is an excellent tool, but not perfect: a guide to counseling patients considering PGS. Fertil Steril. 2016;105(1):49–50. https://doi.org/10.1016/j.fertnstert.2015.09.042.
Sills SE, Schattman GL, Veeck LL, Liu H-C, Prasad M, Rosenwaks Z. Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulationg hormone (FSH) and human menopausal gonadotropin versus FSH alone. Fertil Steril. 1998;69(5):831–5. https://doi.org/10.1016/S0015-0282(98)00046-6.
Schoolcraft WB, Fragouli E, Stevens J, Munne S, Katz-Jaffe MG, Wells D. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril. 2010;94(5):1700–6. https://doi.org/10.1016/j.fertnstert.2009.10.015.
Ly KD, Agarwal A, Nagy ZP. Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo? J Assist Reprod Genet. 2011;28(9):833–49. https://doi.org/10.1007/s10815-011-9608-7.
Yang Z, Liu J, Collins GS, Salem SA, Liu X, Lyle SS, et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet. 2012;5(1):24. https://doi.org/10.1186/1755-8166-5-24.
Bodurtha J, Strauss JF. Genomics and perinatal care. N Engl J Med. 2012;366(1):64–73. https://doi.org/10.1056/NEJMra1105043.
Arian S, Westerfield L, Erfani H, Nassef S, Buffie A, Gibbons WE, et al. Genetic screening and testing in pregnancies conceived by in vitro fertilization (IVF) with preimplantation genetic screening (PGS). Fertil Steril. 2017;108(3):e292. https://doi.org/10.1016/j.fertnstert.2017.07.861.
Takyi A, Santolaya-Forgas J. Prenatal screening for chromosomal abnormalities in IVF patients that opted for preimplantation genetic screening/diagnosis (PGS/D): a need for revised algorithms in the era of personalized medicine. J Assist Reprod Genet. 2017;34(6):723–4. https://doi.org/10.1007/s10815-017-0907-5.
Funding
Supported by the Northwestern Memorial Foundation Evergreen Grant (to MEP) and P50 HD076188 (MEP, PI: T. Woodruff).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kimelman, D., Confino, R., Confino, E. et al. Do patients who achieve pregnancy using IVF-PGS do the recommended genetic diagnostic testing in pregnancy?. J Assist Reprod Genet 35, 1881–1885 (2018). https://doi.org/10.1007/s10815-018-1289-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-018-1289-z